Arkolith/Insider Trading/OTLK/Form 4

Haddadin Yezan Munther

DirectorOutlook Therapeutics, Inc. (OTLK) · full profile →Form 4 · filed Oct 3, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 3, 2025Grant(A)96K—$096K
Oct 1, 2025Grant(A)287K—$0287K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001649989-25-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML